Clinical Trial Update: Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study) [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, placebo-controlled trial evaluated a controlled-release formulation of paroxetine in major depressive disorder; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Paxil CR (paroxetine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-11-15